Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Daridorexant Treatment for Chronic Insomnia in Restless Legs Syndrome
Luca Fernando1, Mariana Fernandes2, Anna Castelnuovo3
1Neurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.
Background:
Insomnia is common in restless legs syndrome (RLS), significantly impairing quality of life. Dual orexin receptor antagonists (DORAs) have demonstrated efficacy in managing insomnia and RLS symptoms. Daridorexant is a recently approved DORA for insomnia disorder.
Objectives:
Evaluate the effectiveness of daridorexant 50 mg/night in treating insomnia in patients with RLS.
Methods:
This multicenter prospective observational study included 21 patients with RLS and insomnia, evaluated at baseline and after 3 months of treatment with daridorexant 50 mg/night using Insomnia Severity Index (ISI), International Restless Legs Syndrome Study Group Rating Scale (IRLS), Beck Depression Inventory-II (BDI-II), and a visual analogue scale for sleep quality.
Results:
Sixteen patients completed follow-up. Significant improvements were observed at follow-up in ISI (P = 0.001), IRLS (P = 0.001) and BDI-II scores (P = 0.001), and sleep quality (P < 0.001).
Conclusions:
Daridorexant 50 mg/night improved insomnia, RLS, depressive symptoms, and sleep quality in RLS patients, supporting its potential use in this population.
More Related Videos
Related Concept Videos
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
REM Sleep Behavior Disorder
RBD is significantly associated with...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Narcolepsy

